Abstract Results

Click on an Abstract below for more information.

338 matches found
Poster/E-Poster Number Title
1 ACUTE KIDNEY INJURY DUE TO PLASMABLASTIC LEUKEMIA
2 Anuric renal failure following limited dermal exposure to chromic acid
3 OPTIMUM METHODOLOGY FOR ESTIMATING BASELINE SERUM CREATININE FOR THE ACUTE KIDNEY INJURY DIAGNOSIS AND STAGING
4 ACUTE KIDNEY INJURY POST CARDIAC SURGERY: INCIDENCE, MORTALITY, RENAL RECOVERY, AND QUALITY OF LIFE IN THOSE REQUIRING CONTINUOUS VENO-VENOUS HEMOFILTRATION
5 GABAPENTIN INDUCED ACUTE KIDNEY INJURY AND MANAGEMENT WITH HEMODIALYSIS
6 Dialysis dependent renal failure due to gemcetabine induced TTP
7 DIALYSIS REQUIREMENT AND LONG-TERM MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) IN HOSPITAL ACQUIRED ACUTE KIDNEY INJURY (AKI) – A PROPENSITY-MATCHED COHORT STUDY
8 TREATMENT OF HYPONATREMIA IN HEPATORENAL PATIENTS WITH MIDODRINE AND OCTREOTRIDE.
9 CORRELATION BETWEEN RENAL RESISTIVE INDEX, CENTRAL VENOUS PRESSURE, AND MEAN ARTERIAL PRESSURE IN SEPTIC ICU PATIENTS WITHOUT PRIOR RENAL DISEASE
10 Anticoagulation related nephropathy presenting as gross hematuria and oliguric AKI.
11 PYRIDORIN-TM TREATMENT IN MOUSE MODELS OF AKI
12 USE OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM BLOCKADE (RAASB) MAY BE BENEFICIAL IN PATIENTS WITH ACUTE KIDNEY INJURY (AKI)
13 RARE PRESENTATION OF ACUTE RENAL FAILURE WITH OBSTRUCTIVE NEPHROPATHY IN OVARIAN HYPERSTIMULATION
14 ACUTE KIDNEY INJURY ADJUSTED TO FLUID STATUS IN CRITICALLY ILL PATIENTS: EVALUATION OF DELAYED DIAGNOSIS AND ASSOCIATED OUTCOMES
15 NON-MECHANICAL NEW-ONSET PAINLESS HEMATURIA IN AN ELDERLY: ALTERNATIVE DIAGNOSIS
16 ACUTE RESCUE HEMODIALYSIS IN A PATIENT WITH ANTIBIOTIC IMPREGNATED KNEE CEMENT SPACER PREVENTING KIDNEY INJURY: AN INNOVATIVE APPROACH
17 PANTOEA AGGLOMERANS: AN UNUSUAL CAUSE OF CATHETER-RELATED SEPSIS IN HEMODIALYSIS PATIENT
18 MINIMAL CHANGE DISEASE ON TOP OF LUPUS NEPHRITIS CLASS II
19 CISPLATIN AND DIABETES INSIPIDUS (DI)
20 PSEUDOTUMOR CEREBRI: AN UNUSUAL PRESENTATION OF IG A NEPHROPATHY
21 SCLERODERMA RENAL CRISIS: MORE EVIDENCE OF ACE INHIBITORS SUPERIORITY OVER ANGIOTENSIN-RECEPTOR BLOCKERS.
22 First Report of Human Intestinal Spirochetosis in Kidney Transplant Recipient
23 IgD MULTIPLE MYELOMA PRESENTING AS LIGHT CHAIN NEPHROPATHY WITH ACUTE TUBULAR NECROSIS
24 Pregnancy induced Microangiopathy, HELLP or TTP !
25 Calcific Uremic Arteriolopathy successfully treated with Sodium Thiosulfate.
26 LYSOZYME INDUCED ACUTE KIDNEY INJURY
27 An Unusual Case of IgA Nephropathy
28 ANCA GLOMERULONEPHRITIS IN ASSOCIATION WITH MYASTHENIA GRAVIS
29 RENAL TUBULAR NEUTROPHILIC CASTS IN PATIENT WITH SWEET SYNDROME
30 PROFOUND AND PROLONGED HYPOCALCEMIA IN A PATIENT ON DENOSUMAB AND CINACALCET.
31 ANCA-NEGATIVE PAUCI-IMMUNE CRESCENTIC GLOMERULONEPHRITIS LINKED WITH NON SMALL CELL CARCINOMA OF THE LUNG
32 INTRAGLOMERULAR METASTASIS PATHOGENESIS, DIAGNOSIS, TREATMENT, AND PROGNOSIS
33 TREATING MULTIPLE SYSTEM ATROPHY: BE SURE THE TREATMENT IS NOT WORSE THAN THE DISEASE
34 DOUBLE TROUBLE: A RARE CASE OF XANTHOGRANULOMATOUS WITH SUPERIMPOSED EMPHYSEMATOUS PYELONEPHRITIS
35 LUPUS RELATED POLYAUTOIMMUNITY IN MEMBRANOUS GLOMERULOPATHY
36 “DEAD ON ARRIVAL”: A SYNTHETIC CANNABINOID WITH DETRIMENTAL EFFECTS
37 RECURRENT FOCAL SEGMENTAL GLOMERULAR SCLEROSIS FOLLOWING HLA IDENTICAL LIVING DONOR KIDNEY TRANSPLANTATION
38 EARLY PLASMAPHERESIS IN THE TREATMENT OF ACUTE CAST NEPHROPATHY
39 A CURIOUS CASE OF HYPERTENION AND HYPOKALEMIA AFTER LICORICE CONSUMPTION
40 RECURRENT NEPHROLITHIASIS SECONDARY TO GUAIFENESIN ABUSE
41 USE OF PLASMA EXCHANGE FOR DIGOXIN TOXICITY IN ANURIC ACUTE RENAL FAILURE
42 Successful treatment of post-transplant collapsing glomerulopathy with a rituximab-based regimen
43 MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS SECONDARY TO LIGHT CHAIN DEPOSITION DISEASE: A RARE CASE OF MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE
44 FOCAL CRESCENTIC AND NECROTIZING PROLIFERATIVE GLOMERULONEPHRITIS WITH CRYSTALLINE LIGHT CHAIN DEPOSITS: A UNIQUE LIGHT CHAIN ASSOCIATED PATTERN OF INJURY
45 HYDRONEPHROSIS FROM COAPTITE CRYSTALS IN A PATIENT WITH URINARY INCONTINENCE
46 Enoxaparin Implicated in a Case of Atheroembolic Renal Failure
47 LEGAL, BUT IS IT SAFE? CASE OF RECURRENT ACUTE KIDNEY INJURY ASSOCIATED TO SYNTHETIC CANNABIONOID USE
48 RECURRENT RENAL INFARCTION IN AN OTHERWISE HEALTHY ACTIVE DUTY MALE
49 INTERACTION BETWEEN TACROLIMUS, ATORVASTATIN, AND LEVOFLOXACIN-AN UNREPORTED DRUG-DRUG INTERACTION
50 SEVERE HYPOPHOSPHATEMIA ASSOCIATED WITH SPONTANEOUS TUMOR LYSIS SYNDROME
51 CALCIPHYLAXIS IN A PATIENT WITH NORMAL RENAL FUNCTION AND ALCOHOLIC LIVER CIRRHOSIS SUCCESSFULLY TREATED WITH SODIUM THIOSULFATE
52 SUPPLEMENT ASSOCIATED ACUTE KIDNEY INJURY IN TWO OTHERWISE HEALTHY ATIVE DUTY SOLDIERS
53 NEW DIAGNOSIS OF BULLOUS PEMPHIGOID AFTER WITHDRAWAL OF IMMUNOSUPPRESSIVE THERAPY IN A FAILED RENAL TRANSPLANT RECIPIENT ON HEMODIALYSIS
54 AML ASSOCIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
55 FLUDARABINE/CYTARABINE ASSOCIATED COLLAPSING FSGS
56 PLASMACYTOMA-LIKE PTLD, RARE SUBTYPE OF MONOMORPHIC B-CELL POST-TRANSPLANT LYMPHOPROLIFERATION
57 ERYTHROCYTOSIS IN A PATIENT WITH GITELMAN’S SYNDROME
58 ADRENOCORTICOTROPIC HORMONE GEL AND COLLAPSING VARIANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS
59 OUT OF THE FRYING PAN AND INTO THE FIRE: RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS SECONDARY TO ADALIMUMAB.
60 TREATMENT OF GLOMERULAR TIP LESION IN A PATIENT WITH DIALYSIS-DEPENDENT KIDNEY DISEASE.
61 CALCIPHYLAXIS IN CHRONIC KIDNEY DISEASE WITH HISTORY OF GASTRIC BYPASS.
62 Three Different Journeys: All Trying to Resist CMV
63 AN UNUSUAL CASE OF VITAMIN D INTOXICATION PRESENTING WITH HYPOCALCEMIA
64 RENAL LIMITED THROMBOTIC MICROANGIOPATHY DIAGNOSED 7 YEARS AFTER BONE MARROW TRANSPLANT
65 MINIMAL CHANGE DISEASE ASSOCIATED WITH RANIBIZUMAB
66 A RARE CASE OF PERITONITIS
67 METHYLPREDNISOLONE FOR PREDNISONE-RESISTANT MINIMAL CHANGE DISEASE
68 PEMBROLIZUMAB AND ACUTE KIDNEY INJURY REQUIRING DIALYSIS
69 IgA Nephropathy Presenting During Pregnancy
70 PREGNANCY IN A PATIENT WITH CYSTINOSIS AND END STAGE KIDNEY DISEASE ON HEMODIALYSIS
71 PEG-Interferon: A Rare Cause of Acute Interstitial Nephritis
72 GRAFT VS HOST DISEASE - A RARE CAUSE OF HYPONATREMIA
73 Hydralazine as a cause of necrotizing glomerulonephritis with minimal systemic features-a rare clinical presentation!
74 RENAL OUTCOMES IN ACUTE POST-STREPTOCOCCAL GLOMERULONEPHRITIS SUMPERIMPOSED ON DIABETIC NEPHROPATHY
75 EXTRAMAMMARY PAGET’S DISEASE IN A KIDNEY TRANSPLANT RECIPIENT-A CASE REPORT AND REVIEW OF THE LITERATURE
76 PARADOXICAL HYPONATREMIA IN NEPHROGENIC DIABETES INSIPIDUS
77 Reactive amyloidosis caused by Silicone injections: A case report
78 Toxoplasmosis with necrotizing cerebritis in renal transplant patient
79 TUMOR-INDUCED OSTEOMALACIA (TIO) WITH ELEVATED FGF-23 CAUSING HYPOPHOSPHATEMIA IN OVARIAN MALIGNANCY
80 PHENYTOIN TO THE RESCUE OF EXTREME TACROLIMUS TOXICITY
81 UNUSUAL ASSOCIATION OF CHRONIC KIDNEY DISEASE, MULTIPLE SCLEROSIS AND HEART FAILURE.
82 HRS VS CRS ARE YOU LISTENING?
83 ANTI-GBM DISEASE IN ALPORT SYNDROME 10 YEARS LATER
84 MEMBRANOUS NEPHROPATHY DIAGNOSED DURING PREGNANCY
85 AN ANSWER TO RECURRENT NEPHROLITHIASIS AND HYPERVITAMINOSIS D
86 Acute Oxalate Nephropathy in Renal Transplant Patient with Community Acquired Clostridium Difficile
87 FALSE POSITIVE ANTI-HEPATITIS C (HCV) ANTIBODY AFTER A FUNGAL INFECTION
88 UNUSUAL PRESENTATION OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) IN THE NATIVE KIDNEY
89 A TWIST IN THE TALE: AN UNCOMMON CAUSE OF TRANSPLANT FAILURE
90 The curious case of hyperammonemia
91 HYPOPHOSPHATEMIA WITH HYPERPHOSPHATURIA IN A PATIENT TREATED WITH REGORAFENIB
92 LIGHT CHAIN FANCONI SYNDROME IN A PATIENT WITH ACUTE MYELOID LEUKEMIA and MGUS
93 MULTIPLE BILATERAL PULMONARY EMBOLISM FOLLOWING ANGIOPLASTY AND STENT PLACEMENT OF ARTERIOVENOUS GRAFT
94 ACUTE INTERSTITIAL NEPHRITIS SECONDARY TO MONOCLONAL GAMMOPATHY: RAPID IMPROVEMENT IN RENAL FUNCTION WITH CHEMOTHERAPY
95 CASE REPORT: RENAL FAILURE AND MALARIA
96 DE NOVO PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IgG DEPOSITS IN A KIDNEY ALLOGRAFT: A CASE REPORT
97 FIBRILLARY GLOMERULONEPHRITIS PRESENTING AS SEVERE ACUTE KIDNEY INJURY AND CRESCENTIC GLOMERULONEPHRITIS
98 MYCOBACTERIUM AVIUM COMPLEX PERITONITIS IN NON-HIV PERITONEAL DIALYSIS PATIENT
99 AN UNUSUAL CASE OF IGA NEPHROPATHY AND LEUKOCYTOCLASTIC VASCULITIS, COMPLICATED BY PAUCI-IMMUNE RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS (RPGN)
100 Brachio-oto-renal syndrome- a rare cause of end stage renal disease at young age.
101 PRIMARY RENAL CELL CARCINOMA IN A TRANSPLANTED ALLOGRAFT KIDNEY
102 PERFORATION OF THE GREAT VESSELS DURING TUNNELED INTERNAL JUGULAR DIALYSIS CATHETER PLACEMENT
103 SERONEGATIVE ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE RESULTING IN DIALYSIS DEPENDENCE
104 MINOXIDIL-INDUCED SEVERE REVERSIBLE NON-ISCHEMIC CARDIOMYOPATHY
105 COCCIDIODOMYCOSIS MASQUERADING AS BREAST MASS
106 SUSTAINED LOW EFFICIENCY HEMODIALYSIS FOR REMOVAL OF DABIGATRAN
107 REDUCTION IN REPEAT HOSPITALIZATIONS IN A PATIENT WITH LOIN PAIN HEMATURIA SYNDROME USING OUTPATIENT HYDRATION
108 DISSEMINATED ADENOVIRAL GRANULOMATOUS INTERSTITIAL NEPHRITIS IN A SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT RECIPIENT
109 KINETIC GLOMERULAR FILTRATION RATE: CLINICAL UTILITY IN MANAGING ACUTE KIDNEY INJURY
110 LIFE-THREATENING NECROTIZING MUCORMYCOSIS PNEUMONIA IN A HIGHLY SENSITIZED KIDNEY TRANSPLANT RECIPIENT: BALANCE BETWEEN INFECTIOUS RISK AND SUCCESSFUL TRANSPLANTATION
111 PINK URINE IN A MORBIDLY OBESE LYMPHOMA PATIENT
112 HYPERNATREMIA FROM CENTRAL DIABETES INSIPIDUS IN ACUTE MYELOGENOUS LEUKEMIA
113 A CASE OF CUTANEOUS EXOPHILIA IN A KIDNEY TRANSPLANT RECIPIENT.
114 OVARIAN HYPERSTIMULATION SYNDROME CAUSING ATYPICAL RENAL DISEASE
115 NEPHROTIC SYNDROME AND POLYCYTHEMIA
116 WHERE IS THE GAP COMING FROM ? A CASE REPORT
117 PROBENECID-INDUCED COLLAPSING GLOMERULOPATHY
118 AORTIC DISSECTION: A RARE CAUSE OF ACUTE KIDNEY INJURY
119 ETHYLENE GLYCOL INGESTION WITH SEVRELY ELEVATED OSMOLAR AND ANION GAP; A REMARKABLE SURVIVAL AND RECOVERY
120 SUCCESSFUL TREATMENT OF ATYPICAL HUS IN A KIDNEY TRANSPLANT RECIPIENT WITH ECULIZUMAB AND BELATACEPT
121 EVALUATION OF DELAYED ESA INITIATION IN THE INPATIENT SETTING
122 COMPARISON OF THE SAFETY OF FOUR DIFFERENT INTRAVENOUS IRON FORMULATIONS IN CKD PATIENTS WITH IRON DEFICIENCY ANEMIA. N. R. Dossabhoy, R. Vejella, D. Brignac, S. Khan, A. Kallam; VA Medical Center and LSU Health, Shreveport, LA.
123 AURYXIA (FERRIC CITRATE), AN ORAL IRON-BASED PHOSPHATE BINDER, SIGNIFICANTLY IMPROVES SERUM IRON MEASURES IN PATIENTS WITH STAGE 3, 4 AND 5 CHRONIC KIDNEY DISEASE (CKD)
124 TRIFERIC DOES NOT INCREASE PREDIALYSIS HEPCIDIN LEVELS OR IRON SEQUESTRATION: THE PRIME STUDY
125 TRIFERIC ADMINISTERED VIA DIALYSATE MAINTAINS HEMOGLOBIN LONG TERM: RESULTS OF THE CRUISE OPEN-LABEL STUDIES
126 TRIFERIC DOES NOT INDUCE OXIDATIVE STRESS IN CKD-HD: THE PRIME STUDY.
127 HEPCIDIN EXPRESSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
128 THE FACT-STUDY – A RANDOMIZED CONTROLLED TRIAL OF REPEATED DOSES OF FERUMOXYTOL OR IRON SUCROSE IN PATIENTS ON HEMODIALYSIS: BACKGROUND AND RATIONALE
129 LABILE IRON RELEASE FROM INTRAVENOUS (IV) IRON FORMULATIONS: CONSIDERATIONS FOR BIOEQUIVALENCE
130 IRON STORES ARE INCREASED WITHIN THE FIRST 24 WEEKS AND MAINTAINED FOR 80 ADDITIONAL WEEKS WITH LONG-TERM USE OF ORAL FERRIC CITRATE (FC) AS A PHOSPHATE BINDER
131 POST HOC ANALYSIS OF ANTIANEMIC AGENT USE OVER 1 YEAR IN A PHASE 3 STUDY OF SUCROFERRIC OXYHYDROXIDE
132 EPOETIN HOSPIRA AND EPOGEN® (AMGEN) PK/PD EQUIVALENCE FOLLOWING SINGLE SUBCUTANEOUS DOSES TO HEALTHY SUBJECTS
133 EPOETIN HOSPIRA AND EPOGEN® (AMGEN) PD/PK EQUIVALENCE FOLLOWING MULTIPLE SUBCUTANEOUS DOSES TO HEALTHY SUBJECTS
134 DOSE CYCLING PATTERNS IN EPOETIN ALFA USE IN UNITED STATES HEMODIALYSIS PATIENTS
135 ORAL VITAMIN C SUPPLEMENTATION FOR FUNCTIONAL IRON DEFICIENCY IN DIALYSIS PATIENTS
136 DEVELOPMENT OF A HEALTH RELATED QUALITY OF LIFE (HRQOL) MEASURE FOR ANEMIA IN END STAGE RENAL DISEASE (ESRD)
137 TIMELY DATA REPORTING IS ASSOCIATED WITH IMPROVEMENTS IN SYSTOLIC HYPERTENSION AND FLUID OVERLOAD IN DIALYSIS PATIENTS
138 LEAD EXPOSURE AND THE RISK OF ESRD, STROKE, MYOCARDIAL INFARCTION, AND DEATH AMONG HISPANICS WITH CKD: THE PASO DEL NORTE KIDNEY DISEASE STUDY (PNKDS)
139 Ethnic Differences in Serum Phosphorus Levels in an Inner City Minority Population Receiving Hemodialysis
140 CHRONIC KIDNEY DISEASE, DIABETES STATUS AND MORTALITY IN UNITED STATES ADULTS: NHANES 1999-2004
141 CHALLENGES IN ESTIMATING THE HOSPITALIZATION RATE FOR HEART FAILURE
142 SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) IN HYPERKALEMIC PATIENTS WITH CKD ON RAAS INHIBITORS: SUBGROUP ANALYSIS OF PHASE 3 HARMONIZE STUDY
143 Myocardial Infarction Management in Patients with Chronic Kidney Disease Stage 3-5, End Stage Renal Disease, and Normal Kidney Function: a Retrospective Cohort Study
144 HIGHER ACUTE KIDNEY INJURY (AKI) RISK IN FEMALES POST CARDIAC SURGERY IS RELATED TO DIFFERENCES IN BASELINE HEALTH
145 A CHALLENGING CASE OF CALCIPHYLAXIS: Sai Atluri, Krishna Baradhi, University of Oklahoma, Tulsa, OK, USA
146 AURYXIA (FERRIC CITRATE) EFFECTIVELY REDUCES SERUM PHOSPHATE AND FIBROBLAST GROWTH FACTOR 23 (FGF23) LEVELS IN PATIENTS WITH STAGES 3-5 CHRONIC KIDNEY DISEASE (CKD)
147 TREATMENT EFFECT AND SAFETY OF HIGH FLUID INTAKE FOR THE PREVENTION OF INCIDENT AND RECURRENT KIDNEY STONES: A META-ANALYSIS
148 SERUM PHOSPHOROUS ENCHANCES THE VALUE OF SERUM PTH FOR PREDICTION OF LOW TURNOVER BONE DISEASE IN PATIENTS WITH CKD-5D
149 FACILITY-LEVEL CKD-MBD BIOCHEMICAL CONTROL AND RISK OF ADVERSE CLINICAL OUTCOMES AMONG PATIENTS ON HEMODIALYSIS (HD)
150 CHITOSAN; A NOVEL SALIVARY PHOSPHOROUS BINDER
151 ADHERENCE RATES AND PREDICTORS OF ADHERENCE TO FERRIC CITRATE AS COMPARED TO ACTIVE CONTROL IN END STAGE KIDNEY DISEASE
152 CKD patient understanding of phosphorus and metabolic bone disease in a nephrology practice
153 ASSESSING 24-HOUR URINARY EXCRETION OF LITHOGENIC FACTORS FROM SPOT URINE SAMPLES
154 ASSOCIATION OF FACILITY-LEVEL SERUM PHOSPHATE WITH MORTALITY AND HOSPITALIZATION RATES IN HEMODIALYSIS PATIENTS
155 LARGE EFFECT OF DEMOGRAPHICS ON URINARY RISK FACTORS FOR KIDNEY STONES
156 MODIFIED-RELEASE CALCIFEDIOL IS EFFECTIVE FOR SHPT IN BOTH STAGES 3 AND 4 CKD
157 Serum Phosphorus Levels, Race and Socio-economic Status in Incident Hemodialysis Patients
158 HEPATITIS B IMMUNIZATION SHOULD START EARLY IN CHRONIC KIDNEY DISEASE PATIENTS
159 PATIENTS PERCEIVED ROLE IN THE CHOICE OF DIALYSIS MODALITY: THE EMPOWERING PATIENTS ON CHOICES FOR RENAL REPLACEMENT THERAPY (EPOCH-RRT) STUDY
160 ASSOCIATION OF BLOOD CADMIUM AND LEAD WITH PREVALENCE OF CHRONIC KIDNEY DISEASE (CKD) IN THE KOREA AND US NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEYS (NHANES)
161 SERUM POTASSIUM AND OUTCOMES IN CHRONIC KIDNEY DISEASE (CKD)
162 ABDOMINAL OBESITY AND CHRONIC KIDNEY DISEASE (CKD) IN A YOUNG POPULATION WITH NORMAL BLOOD PRESSURES AND NORMOGLYCEMIA: RESULTS FROM NHANES 1999-2010.
163 TELENEPHROLOGY FOR THE REMOTE MANAGEMENT OF CHRONIC KIDNEY DISEASE: A RETROSPECTIVE COHORT STUDY
164 IMPROVING PREDICTION OF ARTERIOVENOUS FISTULA (AVF) FAILURE TO MATURE (FTM) BY COMBINING CLINICAL AND SURGICAL ASSESSMENTS
165 UNEXPLAINED GEOGRAPHIC AND FACILITY VARIATION IN THE INITIAL USE OF TEMPORARY NON-TUNNELED CATHETERS FOR CHRONIC DIALYSIS PATIENTS
166 The use of bedside ultrasonography in an outpatient dialysis center in different scenarios
167 IMPACT OF INTERVENTION TO PROMOTE MATURATION ON SURVIVAL OF ARTERIOVENOUS FISTULAS AND GRAFTS.
168 PULMONARY HYPERTENSION DEVELOPS FOLLOWING ARTERIO-VENOUS FISTULA PLACEMENT FOR HEMODIALYSIS
169 LIPOTEICHOIC ACID AS A NON-INVASIVE MARKER OF BIOFILM BURDEN IN HEMODIALYSIS (HD) PATIENTS
170 ASPERGILLUS FUNGEMIA PRESENTING AS VASCULITIS IN A HEMODIALYSIS PATIENT.
171 ENHANCING INTEREST IN NEPHROLOGY BY INTRODUCING AMBULATORY CLINIC ROTATION FOR MEDICINE RESIDENTS.
172 CHRONIC KIDNEY DISEASE MANAGEMENT IN PRIMARY CARE SETTING: IMPACT OF EARLY NEPHROLOGY REFERRAL
173 REDUCING BLOOD STREAM INFECTIONS (BSIs) IN PATIENTS ON HEMODIALYSIS (HD)
174 EVALUATION OF THE IMPACT OF CINACALCET TREATMENT ON MISSED DIALYSIS SESSIONS
175 ULTRAPURE DIALYSATE ASSOCIATED WITH HIGHER SERUM ALBUMIN LEVELS IN DIALYSIS PATIENTS
176 DILEMMA REGARDING THE MANAGEMENT OF END STAGE RENAL DISEASE (ESRD) IN PATIENTS WHO DEVELOPED VEGETATIVE STATE (VS)
177 EXIT SITE GENTAMICIN PROPHYLAXIS DOES NOT INCREASE PD RELATED GENTAMICIN RESISTANT (GR) INFECTIONS
178 ASYMPTOMATIC PNEUMOHYDROTHORAX IN A PERITONEAL DIALYSIS PATIENT WITH TUBEROUS SCLEROSIS-A DIAGNOSTIC DILEMMA
179 POST-PARATHYROIDECTOMY STATE AND SERUM ALBUMIN LEVELS IN END-STAGE RENAL DISEASE PATIENTS: NO APPARENT EFFECT OF SURGICAL PARATHYRODECTOMY
180 ENHANCED TRYPTOPHAN METABOLISM AND IDO ACTIVITY IN CKD
181 EFFECTS OF NURSE LED MOTIVATIONAL INTERVIEWING ON TREATMENT ADHERENCE IN HEMODIALYSIS CLINICS
182 CHARACTERIZATION OF THE CLINICAL CONTEXT FOR THE ADMINISTRATION OF RED BLOOD CELL TRANSFUSIONS IN PATIENTS REQUIRING CHRONIC DIALYSIS.
183 GRAM-NEGATIVE BACTEREMIA OUTBREAK AND DIALYZER REUSE
184 EFFECT OF SENNA ON REDUCTION OF UREMIC PRURITUS IN HEMODIALYSIS PATIENTS: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TIRAL
185 PREVALENCE AND CONTENTS OF ADVANCE DIRECTIVES (AD) AMONG PATIENTS WITH END STAGE KIDNEY DISEASE (ESKD) RECEIVING IN-CENTER HEMODIALYSIS
186 LOWER HOSPITAL ADMISSION RATE WAS ASSOCIATED WITH GREATER REDUCTION IN RELATIVE BLOOD VOLUME IN HEMODIALYSIS PATIENTS
187 TYPE A MEMBRANE REACTION IN AN ESRD PATIENT EXPOSED TO PUREMA POLYSULPHONE MEMBRANE
188 SUCROFERRIC OXYHYDROXIDE DOES NOT AFFECT VARIOUS METHODS FOR DETECTING BLOOD IN STOOL: AN IN VITRO ANALYSIS
189 ASSOCIATION BETWEEN MARKERS OF INFLAMMATION AND RAPID EGFR DECLINE IN PATIENTS WITH RHEUMATOID ARTHRITIS
190 WORKING TOWARDS RISK STRATIFICATION AND PROVISION OF COORDINATED CARE: AN ENDSTAGE RENAL DISEASE (ESRD) PILOT PROGRAM
191 PATIENT PERSPECTIVES ON CHRONIC KIDNEY DISEASE SELF-MANAGEMENT
192 Pneumatosis Intestinalis in a Peritoneal Dialysis patient a rare complication
193 SAFETY AND EFFICACY OF AN INTRADIALYTIC CORE STRENGTHENING PROGRAM AND ITS IMPACT UPON FALLS
194 PREDICTIVE MODELING IS ASSOCIATED WITH REDUCTIONS IN HOSPITAL ADMISSIONS IN DIALYSIS PATIENTS
195 Near Death Experiences in Patients on Hemodialysis
196 DIALYSIS ADHERENCE AND SAFETY IN ESRD PATIENTS ON CHRONIC HEMODIALYSIS
197 EFFECTS OF PHOSPHATE BINDERS ON MORTALITY AND PROGRESSION TO ESRD IN CKD POPULATION
198 IMPLICATIONS OF LOW AND HIGH PLATELET COUNTS AND MORTALITY RISK IN A NATIONAL INCIDENT HEMODIALYSIS COHORT
199 MEAN PLATELET VOLUME AS A NOVEL RISK FACTOR FOR MORTALITY IN HEMODIALYSIS PATIENTS
200 ASSOCIATION OF RECOVERY TIME WITH KDQOL-36 IN US HEMODIALYSIS PATIENTS
201 RECOVERY TIME & SHORT TERM OUTCOMES IN US HEMODIALYSIS PATIENTS
202 IDENTIFYING INFORMATION NEEDS AMONG VETERANS WITH CHRONIC AND END-STAGE KIDNEY DISEASE
203 DON’T BE TRICKED BY MDRD: HOW TO APPROACH FOR ESTIMATING GFR OF BILATERAL LEG AMPUTEE
204 SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) FOR HYPERKALEMIA IN STAGE 4/5 CKD SUBGROUP OF THE PHASE 3 HARMONIZE STUDY
205 HIGHER PLASMA TRANSFORMING GROWTH FACTOR (TGF)-β IS ASSOCIATED WITH KIDNEY DISEASE IN OLDER COMMUNITY-DWELLING ADULTS
206 Risk of hospitalization with major non-traumatic hemorrhage among patients with chronic kidney disease
207 ASSOCIATION OF HEALTH LITERACY WITH MEDICATION SELF-MANAGEMENT
208 PREVALENCE AND CORRELATES OF MEDICATION ADHERENCE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
209 CONTINUOUS QUALITY IMPROVEMENT (CQI) APPLICATIONS IN NEPHROLOGY: A SYSTEMATIC REVIEW
210 OPPORTUNITIES TO IMPROVE CKD EDUCATION: GAINING INSIGHTS FROM PATIENTS USING QUALITATIVE METHODS AND TOTAL QUALITY MANAGEMENT
211 AGREEMENT BETWEEN KIDNEY FUNCTION ESTIMATES FOR DRUG DOSING IN A HOSPITALIZED VETERAN POPULATION
212 UTILITY OF BIOELECTRICAL IMPEDANCE SPECTROSCOPY (BIS) WITH ELECTRICAL IMPEDANCE TOMOGRAPHY (EIT) TO EVALUATE REGIONAL VOLUME FLUX IN HEMODIALYSIS (HD) PATIENT
213 Pharmacokinetic Study of Cefazolin in Short Daily Hemodialysis
214 RECENT DECREASE IN DEATH RATES AMONG DIALYSIS PATIENTS
215 RECENT DECREASE IN HOSPITALIZATION RATES AMONG DIALYSIS PATIENTS
216 REGIONAL VARIATION IN MORTALITY RATES OF INCIDENT DIALYSIS PATIENTS
217 SEASONALITY OF HOSPITALIZATION FOR PNEUMONIA, INFLUENZA, AND DIALYSIS ACCESS INFECTION
218 Title: Ergocalciferol supplementation does not reduce the rate of infections and all-cause mortality in hemodialysis (HD) patients
219 USING IN-CENTER HEMODIALYSIS CONSUMER ASSESSMENT OF HEALTHCARE PROVIDERS AND SYSTEMS (ICH-CAHPS) RESULTS TO MEASURE IMPROVEMENT IN PATIENT-PROVIDER COMMUNICATION IN THE DIALYSIS SETTING.
220 RELATIONSHIP BETWEEN THYROTROPIN AND FREE THYROXINE MEASURED BY TANDEM MASS SPECTROMETRY AND IMMUNOASSAY IN HEMODIALYSIS PATIENTS
221 PREGNANCY OUTCOMES IN HEMODIALYSIS PATIENTS: A NATIONAL SURVEY
222 Migration to Heparin-Free Hemodialysis (HD) with Streamline® Airless Bloodlines (SL) in a Large Inpatient Practice
223 CREATININE CLEARANCE AND eGFR: ACCURACY OF ESTIMATION OF RENAL FUNCTION IN ELDERLY PATIENTS
224 “TALKING CONTROL” AS A METHOD TO IMPROVE PATIENT SATISFACTION WITH STAFF COMMUNICATION IN THE DIALYSIS SETTING.
225 INSUFFICIENT RISK ADJUSTMENT OF QUALITY METRICS FOR A NICHE DIALYSIS PROVIDER
226 DESIGN OF A PHASE 3 CLINICAL TRIAL IN DIABETIC NEPHROPATHY WITH PYRIDORIN
227 Heavy Proteinuria > 50 Grams- Is it DIABETES OR SOMETHING ELSE
228 TRENDS IN DIABETES PREVALENCE, AWARENESS, TREATMENT AND CONTROL IN OLDER ADULT GENERAL AND CKD POPULATIONS OF THE UNITED STATES, 1999-2012
229 HYPERCALCEMIA OF IMMOBILIZATION IN RENAL FAILURE– A CASE REPORT
230 HYPOMAGNESEMIA LINKED TO DEPRESSION: A META-ANALYSIS
231 USE OF PROTON PUMP INHIBITORS AND THE RISK OF HYPOMAGNESEMIA: A META-ANALYSIS OF OBSERVATIONAL STUDIES
232 SEVERE METABOLIC ALKALOSIS AND RESPIRATORY ACIDOSIS WITH HYPOKALEMIA
233 PHOSPHORUS LEVEL > 12 mg/dl WITH NORMAL CREATININE AND CALCIUM LEVEL, MAKE YOUR DIAGNOSIS!
234 VARYING BICARBONATE CONCENTRATIONS OF NATURALYTE DIALYSATE SOLUTION CAUSES RAPID INTER AND INTRADIALYTIC FLUCTUATIONS IN SERUM BICARBONATE LEVELS
235 INCIDENCE OF HYPOGLYCEMIA IN PATIENTS WITH LOW GFR TREATED WITH INSULIN AND DEXTROSE FOR HYPERKALEMIA
236 SAFETY OF SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) IN HYPERKALEMIA: ANALYSIS OF GI EFFECTS IN THE PHASE 3 HARMONIZE STUDY
237 PRE-DIALYSIS SERUM SODIUM AND MORTALITY IN A NATIONAL INCIDENT HEMODIALYSIS COHORT
238 IN VITRO COMPARISON OF WATER ABSORPTION BY HYPERKALEMIA THERAPIES: SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) VS ORGANIC POLYMER RESIN
239 Hypernatremia: A Surrogate Marker For Sepsis?
240 PATIROMER REDUCED RECURRENT HYPERKALEMIA IN ADVANCED CKD PATIENTS ON RAASI
241 VARIABILITY OF ARGININE VASOPRESSIN LEVELS IN HOSPITALIZED PATIENTS WITH HYPONATREMIA
242 PLACEBO EFFECT IN CLINICAL STUDIES IN HYPERKALEMIA: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9)
243 ATYPICAL HEMOLYTIC UREMIC SYNDROME, A SUCCESSFUL STORY
244 PROLIFERATIVE C4 DENSE DEPOSITION DISEASE CONCURRENT WITH ACUTE THROMBOTIC MICROANGIOPATHY IN AN ADULT PATIENT WITH ACUTE RENAL FAILURE
245 SERONEGATIVE LUPUS NEPHRITIS PRESENTING WITH MALARIA: A CLINICAL CONUNDRUM
246 KIDNEY DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS PATIENTS IS NOT ALWAYS HIV-ASSOCIATED NEPHROPATHY (HIVAN), BUT HIV IMMUNE COMPLEX KIDNEY DISEASE (HIVICK) AS WELL
247 SEVERE FLARE OF HYPOTHYROIDISM WITH THE ONSET OF NEPRHROTIC SYNDROME
248 CATASTROPHIC INTRACEREBRAL HEMORRHAGE, A RARE CONSEQUENCE OF IMMUNOSUPPRESSION IN GRANULOMATOSIS WITH POLYANGIITIS
249 H .P. ACTHAR® GEL IN PATIENTS WITH IGA NEPHROPATHY, MEMBRANOUS LUPUS NEPHRITIS AND MINIMAL CHANGE DISEASE: A RETROSPECTIVE CASE SERIES
250 2nd Recurrence of Idiopathic Membranous Nephropathy (IMN) in a Kidney Transplant Successfully treated with Rituximab
251 SERUM ALBUMIN AS A QUANTITATIVE DEFINITION OF NEPHROTIC SYNDROME
252 NOVEL AMYLOID PROTEIN: A CAUSE OF NON-PROTEINURIC KIDNEY DISEASE
253 GEMCITABINE INDUCED THROMBOTIC MICROANGIOPATHY: ROLE OF ECULIZUMAB
254 GLOMERULAR TOOTHMARKS: POST INFECTIOUS GLOMERULONEPHRITIS (PIGN) IN AN IMMUNOSUPPRESSED PATIENT
255 COMPARISON OF SEVERITY OF RENAL FAILURE IN LUPUS AND ANCA ASSOCIATED PATIENTS WITH CRESCENTIC GN:
256 A CASE OF A PREVIOUSLY UNKNOWN AMYLOID SUBTYPE
257 RARE CASE OF LUPUS NEPHRITIS
258 Immunotactoid Glomerulopathy with Membranous Pattern in Patient with Rheumatoid Arthritis and Monoclonal Gammopathy
259 IgA-dominant Staphylococcus infection associated glomerulonephritis with Henoch-Schonlein purpura like presentation.
260 PARTIAL REMISSION OF FIBRILLLARY GLOMERULONEPHRITIS WITH CRESCENTIC AND NECROTIZING FEATURES TREATED WITH H.P. ACTHAR® GEL
261 SECONDARY AMYLOIDOSIS PRESENTING AS ACUTE KIDNEY INJURY.
262 DOXYCYCLINE INDUCED MINIMAL CHANGE DISEASE: FIRST CASE REPORT
263 Hydrothorax as a complication of peritoneal dialysis: is still a cause for treatment failure
264 The utility of advanced data management for better peritoneal dialysis care
265 Novel UV Light System for Disinfection of Peritoneal Dialysis Catheter Connections
266 URGENT-START PERITONEAL DIALYSIS VERSUS OTHER MODALITIES OF DIALYSIS: LONG-TERM OUTCOMES
267 QUALITY IMPROVEMENT: PRACTICAL TECHNIQUES FOR REDUCING PERITONEAL DIALYSIS RELATED INFECTIONS
268 SIX MONTH OUTCOMES OF INCIDENT PD PATIENTS
269 PERITONEAL PROTEIN LOSS WITH AUTOMATED PERITONEAL DIALYSIS (APD) AND CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)
270 DEDICATED PHYSICIAN MODALITY CONSULT FOLLOWING NURSING LED DIALYSIS EDUCATION IMPROVES PERITONEAL DIALYSIS UTILIZATION
271 Bio-impedance in peritoneal dialysis: control over Hyper Hydration and blood pressure
272 Characteristics of Peritoneal Dialysis Patients Using Icodextrin
273 COMPARISON OF MORTALITY RISK FROM VASCULAR ACCESS (VA) COMPLICATIONS BETWEEN THOSE ON HOME VERSUS FACILITY HEMODIALYSIS (HD) IN THE AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY (ANZDATA)
274 Acute Peritonitis in a Patient on Peritoneal Dialysis Following Colonoscopy
275 PREDICTORS OF TRANSITIONING TO HOME
276 PERITONEAL DIALYSIS-RELATED PERITONITIS CAUSED BY STREPTOCCUS BOVIS BIOTYPE-II/1
277 TRANSECTION VS INFECTION: ACUTE APPENDICITIS IN A PERITONEAL DIALYSIS PATIENT MIMICKING CATHETER DYSFUNCTION AND DISCONTINUITY ON X-RAY
278 30-DAY READMISSION RATES AFTER HEART FAILURE AND HYPERTENSIVE DISEASE DISCHARGES IN DAILY HOME HEMODIALYSIS, PERITONEAL DIALYSIS, AND IN-CENTER HEMODIALYSIS PATIENTS
279 INCIDENCE OF KIDNEY TRANSPLANT IN DAILY HOME HEMODIALYSIS, PERITONEAL DIALYSIS, AND IN-CENTER HEMODIALYSIS PATIENTS
280 LOWER RISK OF EARLY DEATH IN INCIDENT DIALYSIS PATIENTS ON DAILY HOME VERSUS IN-CENTER HEMODIALYSIS
281 Silver Nitrate Cautery in Recurrent Peritoneal Dialysis Catheter Exit-site Infection: a case report
282 ORTHOSTATIC HYPOTENSION IN ELDERLY INDVIDUALS WITH CHRONIC KIDNEY DISEASE
283 Angiopietin-Tie2 Activation and Blood Pressure in Mice
284 PAGE KIDNEY-A RARE CAUSE OF ACCELERATED HYPERTENSION
285 Relationship of Central Augmentation Index to Large Artery Stiffness and Distal Vascular Resistance
286 APPLICATION OF THE MEES/OK MODEL OF SODIUM RESTRICTION AND FLUID REMOVAL TO CONTROL BLOOD PRESSURE IN HEMODIALYSIS PATIENTS
287 EFFECT OF USING AUDIO AND VISUAL AIDS FOR INSTRUCTING PATIENTS ABOUT MIDDLE EASTERN HEMODIALYSIS DIET ON KNOWLEDGE AND UNDERSTANDING: Mariam Allaik LD, Department of Clinical Nutrition, American University of Beirut Medical Center, Beirut, Lebanon.
288 DIETARY ACID LOAD: IMPLICATIONS IN THE METABOLIC ACIDOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE.
289 ASSOCIATION OF DIETARY ACID LOAD (DAL) AND CKD AMONG PARTICIPANTS IN JACKSON HEART STUDY (JHS)
290 ANIMAL PROTEIN INTAKE IS ASSOCIATED WITH PROTEIN ADEQUACY IN MAINTENANCE HEMODIALYSIS PATIENTS
291 INTERLEUKIN-10 (IL-10) AND MARKERS OF NUTRITION AND INFLAMMATION IN A STABLE HEMODIALYSIS POPULATION.
292 EFFECT OF DIET EDUCATION ON PHOSPHATE BIOAVAILABILITY ON HYPERPHOSPHATEMIA AND DIET BEHAVIORS IN HEMODIALYSIS PATIENTS
293 ARE THERE ANY NUTRITIONAL STATUS DIFFERENCES AMONG NURSING HOME PATIENTS VERSUS NON-NURSING HOME PATIENTS ON HEMODIALYSIS?
294 PERSONALIZED NUTRITIONAL COUNSELING IN MAINTENANCE HEMODIALYSIS PATIENTS: THE IMPACT DURING SIX MONTHS OF FOLLOW-UP
295 WHICH BODY COMPOSITION AND NUTRITIONAL STATUS MARKERS BEST PREDICT SURVIVAL IN HEMODIALYSIS PATIENTS?
296 A scale to measure gastrointestinal symptoms associated with a single hemodialysis treatment: validation and association with dietary intake during treatment
297 HYPOMAGNESEMIA AND RISK OF ALL-CAUSE MORTALITY IN USA MAINTENANCE HEMODIALYSIS PATIENTS.
298 THE “PHOSPHATE ADDITIVES TREASURE HUNT” (PATH): A SELF-MANAGEMENT APPROACH FOR ENCHANCING PHOSPHATE ADDITIVE EDUCATION IN A MULTI-SITE DIALYSIS PROGRAM
299 INTRADIALYTIC PARENTERAL NUTRITION (IDPN) IN HOME HEMODIALYSIS (HHD) PATIENTS
300 Comparison of Predictive Energy Equations among Individuals on Maintenance Hemodialysis
301 INVESTIGATING THE RELATIONSHIP BETWEEN MEASURED RESTING ENERGY EXPENDITURE AND STEADY STATE AMONG PATIENTS ON MAINTENANCE HEMODIALYSIS
302 DIETITIANS’ OPINIONS ARE CHANGING ON FOOD CONSUMPTION AT TREATMENT
303 Disseminated Toxoplasmosis as the cause of death in a kidney transplant recipient
304 A Comparison of Three Induction Therapies on Patients with Delayed Graft Function after Kidney Transplantation
305 MYELOID-DERIVED SUPPRESSOR CELLS (MDSCS) PREVENT CYCLOSPORINE A-INDUCED HYPERTENSION AND VASCULAR AND RENAL TOXICITY
306 KIDNEY TRANSPLANT RECIPIENTS WHO UNDERWENT PARATHYROIDECTOMY FOR TERTIARY HYPERPARATHYROIDISM
307 HEMORRHAGIC COLITIS DUE TO CYTOMEGALOVIRUS REQUIRING HEMICOLECTOMY IN A KIDNEY TRANSPLANT RECIPIENT
308 Re-Framing the Gift of Life: An Examination of Altruism, Social Distance, and Material Incentives as Factors in Non-Directed Kidney Donor Motivation among Nurses
309 TACROLIMUS TOXICITY AND THERAPEUTIC HYPOTHERMIA AFTER CARDIAC ARREST
310 EVEROLIMUS PREDILECTION TO CAUSE DEEP VENOUS THROMBOSIS (DVT) IN AN ANTI-COAGULATED KIDNEY TRANSPLANT PATIENT
311 THYROTOXICOSIS RELATED TO ANTI-THYMOCYTE GLOBULIN (ATG) IN A RENAL TRANSPLANT RECIPIENT
312 POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER ALEMTUZUMAB INDUCTION IN RENAL TRANSPLANTATION
313 Role of Cinacalcet In Management of Post Renal Transplant Residual Hyperparathyroidism and Hypercalcemia A Retrospective chart review. Abhinandan Pakanati, Keerthi Padooru, Mohanram Narayanan, Texas A&M Health Science Center/Baylor Scott and White Health, Temple, TX, USA
314 DERMATOLOGIC FINDINGS OF LIVER AND KIDNEY TRANSPLANT PATIENTS WITH HEPATITIS C VIRUS: REPORT OF A TWO-YEAR EXPERIENCE FROM A TRANSPLANT DERMATOLOGY CENTER
315 WEIGHT TRENDS IN U.S. LIVING KIDNEY DONORS: ANALYSIS OF THE UNOS DATABASE
316 RECURRENT MEMBRANOUS NEPHROPATHY WITH CRESCENTIC GLOMERULONEPHRITIS IN RENAL ALLOGRAFT
317 NEPHROLOGY AS A CAREER CHOICE - TRENDS FROM URBAN TEACHING HOSPITALS
318 SYMPTOM TARGETED INTERVENTION DECREASED MISSED TREATMENTS IN HEMODIALYSIS PATIENTS
319 NephCure Kidney Network: A new PCORnet vehicle to advance research in primary Nephrotic Syndrome
320 COMPARING TWO MODELS THAT REDUCE THE NUMBER OF NEPHROLOGY FELLOWSHIP POSITIONS IN THE UNITED STATES
321 REAL-TIME DUTY HOUR REPORTING FOR NEPHROLOGY FELLOWS THROUGH A SMARTPHONE APP
322 TUNNELED DIALYSIS CATHETER REMOVAL IS A SKILL THAT CAN BE TAUGHT TO ALL NEPHROLOGY FELLOWS IN TRAINING. Bhupinder Sangha and Neville R. Dossabhoy, LSU Health and VA Medical Center, Shreveport, LA, USA
323 ACUTE SALICYLATE INTOXICATION AS A CAUSE OF LOW SERUM ANION GAP AND PSEUDOHYPERCHLOREMIA.
324 CHANGE IN SERUM PHOSPHORUS AND MORTALITY IN INCIDENT HEMODIALYSIS PATIENTS.
325 LONGITUDINAL CHANGES IN SERUM FERRITIN IN CONTEMPORARY COHORT OF OVER 100,000 INCIDENT HEMODIALYSIS PATIENTS.
326 Assessing raise in Serum Sodium with administration of Conivaptan versus Tolvaptan in the Management of Euvolemic and Hypervolemic Hyponatremia
327 MEDICATION – TAKING PRACTICES AND PREFERENCES IN PATIENTS WITH MULTIPLE CHRONIC MEDICAL CONDITIONS (MCMC)
328 INTERDIALYTIC WEIGHT GAIN MODIFIES THE ASSOCIATION OF HEMODIALYSIS FREQUENCY WITH DECLINE IN RESIDUAL KIDNEY FUNCTION IN INCIDENT DIALYSIS PATIENTS.
329 Pharmacokinetics of Triferic Administered IV to Healthy Volunteers
330 HIGHER VITAMIN B12 LEVELS ARE ASSOCIATED WITH MORTALITY IN HEMODIALYSIS PATIENTS.
331 FATE OF TUBERCULOUS PERITONITIS AND ASPERGILLUS FUMIGATUS CO INFECTION IN A PERITONEAL DIALYSIS PATIENT.
332 RENAL ULTRASOUND AND PROCEDURAL EXPERIENCE OF US ADULT NEPHROLOGY FELLOWS: A NATIONAL SURVEY
333 PEER-TO-PEER MENTORING PROGRAMS IN ESRD
334 COST DRIVERS IN PATIENTS WITH GOUT AND MODERATE TO SEVERE CHRONIC KIDNEY DISEASE (CKD)
335 Survey of Dialysis Technicians
336 VONAPANITASE (PRT-201, RECOMBINANT HUMAN TYPE I PANCREATIC ELASTASE) IMPROVED LONG-TERM RADIOCEPHALIC ARTERIOVENOUS FISTULA (RCF) PATENCY.
337 Neutrolin™, a catheter lock solution (CLS) with no reported human resistance, significantly reduces the rates of infection and thrombosis in hemodialysis patients enrolled in a post-approval surveillance study
338 HOME NOCTURNAL HEMODIALYSIS WITH LOW DIALYSATE VOLUME: A CROSS-OVER STUDY
Back To Top